U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06841042) titled 'A Study of SCTB35 in Patients with Systemic Lupus Erythematosus' on Feb. 11.
Brief Summary: This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
System Lupus Erythematosus
Intervention:
BIOLOGICAL: SCTB35 injection
SCTB35 will be subcutaneously administered at a dose as specified in the respective dose-escalation cohorts. Then, the RP2D and other appropriate doses of SCTB35 will be applied for the dose-expansion cohorts.
Recruitment Statu...